How a necklace helped a woman drop six dress sizes in one year
A necklace was the catalyst for change for a 51-year-old woman who 'ate (her) feelings' to cope with the grief of losing three family members.
Marv Young, from south London, reached her heaviest weight of 110.5kg at 5ft1 tall in 2021 – but she was 'in denial'.
The senior benefits manager had used food as her coping mechanism for grief for years after she lost her 18-year old brother Alan when she was nine, followed by her uncle Douglas when she was 13 and her father Jonathan at 26.
Despite a life-changing multiple sclerosis (MS) diagnosis that same year, it was not until she was gifted a necklace in 2022 that she knew her life needed to change, as it did not fit around her neck.
This led her to the 1:1 Diet by Cambridge Weight Plan and – with one-to-one consultant-led support, weigh-ins and meal replacement products – Marv lost more than 45kg and dropped from a size 22 to 10 in one year.
She now weighs 64.5kg and feels 'phenomenal', and has even become a 1:1 Diet consultant to help others 'feel as good as (she feels)'.
She told PA Real Life: 'I've been fat throughout my whole life… this is the first time in years that I've been slim.
'This whole journey just started off with dropping a few stone and what's happened to me along the way has been amazing.
'I got more than I bargained for, and I feel phenomenal.'
Marv had a normal childhood and played netball at primary school, but when her brother Alan died she started 'emotionally eating'.
'I grew up sharing things with my brother and then, one day, he just wasn't there,' Marv explained.
'Coming from a Caribbean household, food is a form of love, so even though my sibling was no longer there, my mum was still buying the same amount of food.
'She was still shopping the same way and, obviously, I didn't have anyone to share the treats and foods with, so I was just eating them.
'I guess that's when my relationship with food – emotionally eating – happened.'
Aged 13, Marv lost her Uncle Douglas, a taxi driver – and her father, Jonathan, died of heart attack when she was 26, further compounding her trauma.
Sweet treats, including cookies and muffins from Marks and Spencer, became a 'comfort' to her – and she enjoyed Caribbean dishes like curry goat with rice and peas and macaroni and cheese on the side.
She said her weight gradually increased, but she was in denial for many years.
'I was that person where, if the jeans didn't fit, it's the washing machine, if my ring got too tight, my hands are swollen,' she said.
'I was in complete denial.'
Marv had been suffering from back pain for several years, but thought it was related to her 'getting older'.
However, when she started experiencing pins and needles down her body, along with a tightness in her torso, she knew something was not right and sought medical advice.
After numerous tests, MRI scans and a lumbar puncture, in 2021 Marv was diagnosed with MS – a lifelong condition which affects the brain and/or spinal cord.
Studies have shown obesity can increase the risk and severity of the condition, according to the MS Trust.
'I just thought, 'Why me? What have I done to deserve this?'' Marv said.
'I was telling everybody, 'I'm good, I'm alright', but I was eating my emotions, so by the time I got the medication for my MS, I had put on at least another two stone.'
Marv said she reached her heaviest weight of 110.5kg, but it was not until she received a gift in December 2022 that she thought: 'Right, I need to do something.'
She continued: 'My goddaughter bought me a necklace and I couldn't fit the chain around my neck.
'My neck was so fat I couldn't fit the necklace around it… and I thought, 'Oh my God, how embarrassing, can I really go and tell her to change this gift?' And I thought, 'No, you just can't do that'.
'The necklace was the icing on the cake.'
From this point, Marv knew she needed to change her diet and lifestyle.
Her weight was not just affecting her own health – it threatened her ability to care for her 95-year-old mother Sylvia, for whom she is the sole caregiver.
Having previously tried other diets and weight-loss programmes, Marv decided to do some thorough research and came across the 1:1 Diet by Cambridge Weight Plan.
The 1:1 Diet is a tailored weight-loss plan that provides one-to-one consultant support for every dieter and offers a range of meal replacements and products – including pastas, soups, shakes and bars.
Marv started her personalised plan in January 2023 and lost 45kg in one year, with her shoe size even reducing from a UK size 5 to 4.
She said her consultant Deborah Adams was her 'biggest cheerleader', and she now weighs 64.5kg and has dropped six dress sizes – leading her to win the 1:1 Diet Woman of the Year award.
Marv said she now enjoys shopping for clothes as she has 'choice' and she has completely transformed her mindset and relationship with food.
Her MS is currently stable, her medication has reduced and her mobility has improved, and she wants to encourage others to talk about their emotions and 'believe in themselves'.
Marv said: 'I experienced so much grief, but I always believe you have options.
'You can either let things consume you or you can rise above it, so I chose to rise above it and not let it dictate who I am and the person I was becoming.
'I'm a new woman and now the necklace fits.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mirror
12 hours ago
- Daily Mirror
Scientists announce over 100 new dementia meds which could be 'start of a cure'
A global review reveals over 100 new dementia drugs which could halt or even reverse the disease are going through clinical trials - including repurposed weight loss injections Over a hundred new drugs which could halt dementia are being developed at the 'start of a journey to a cure', scientists say. Experts have heralded the findings from a global review of drugs going through clinical trials including repurposing drugs for dementia such as weight loss injections. They say we are at a 'tipping point' in the battle against the devastating disease as a study reveals 138 new dementia drugs are going through clinical trials. Of these, 14% reduce dementia symptoms while 86% could halt or even reverse the disease. Only two such 'disease modifying' drugs are currently licensed and come with a risk of serious side effects. Human trials are looking at whether the appetite-suppressing jab semaglutide - known by its brand names Ozempic for diabetes and Wegovy for weight loss - could also reduce brain inflammation and protect neurons. Sheona Scales, director at Alzheimer's Research UK, said: 'Around a third of drugs in the pipeline are repurposed drugs and a really promising example of this is the drug semaglutide, which is currently being trialed in people with mild cognitive impairment. 'I think it's fair to say today that we're at a tipping point in dementia research as we understand more and more about the diseases that drive dementia. This gives us opportunities to slow and ultimately stop this devastating condition. Today's announcement demonstrates that researchers are able to translate these understandings towards potential new treatments." The 138 drugs are now being tested in 182 clinical trials according to the 2025 review published in the journal Alzheimer's and Dementia: Translational Research and Clinical Interventions. Other existing drugs which could be shown to tackle dementia by lowering brain inflammation include those currently used to treat conditions such as multiple sclerosis (MS) and rheumatoid arthritis. Early evidence suggests semaglutide could also reduce the buildup of harmful amyloid plaques and tau tangles associated with Alzheimer's disease. Emma Mead, Chief Scientific Officer at the Oxford Drug Discovery Institute, which is developing dementia drugs, said in future different combinations of medicines could be prescribed to tackle different stages of the disease. She added: 'Semaglutide is really exciting. There might be some exciting advances around that.' Why are we on the cusp of new dementia drugs? In recent years the first two disease modifying drugs against dementia called lecanemab and donanemab were developed and licensed by UK regulators. However they could benefit only one in ten dementia patients and require a very early stage diagnosis - which lack of testing capacity means most patients don't get. The two drugs also come with a risk of dangerous brain swelling and bleeding. Because of this, and the high cost, they are not approved on the NHS. Lecanemab and donanemab were the first drugs to slow the progression of dementia and do this by directing the immune system to clear away sticky amyloid proteins that accumulate in the brains of Alzheimer's patients. While the risk of serious side effects make them unsuitable for most dementia patients they were proof of the so-called amyloid hypothesis and mean better drugs targeting this protein are now coming through the research pipeline. Consultant neurologist James Rowe, professor of cognitive neurology at Cambridge University, said: 'The newer ones look more effective and they are a start… on a long journey to getting transformative treatments - a cure for a better word.' How could new drugs work against dementia? The global review of dementia drugs led by the University of Nevada in the US revealed amyloid drugs now make up only a third of the 138 drugs being trialled. Some drugs are being developed to protect the synapses - connections between brain cells which become damaged in Alzheimer's patients. Other drugs are being developed which replace the chemical messengers, called neurotransmitters, involved in sending signals between brain cells which decrease in dementia sufferers. Prof Rowe said: 'Amyloid remains very important, an early trigger of the illness, but once people even come within a few years of symptoms, and certainly by the time they reach clinic, there's lots else happening and many other drivers of the illness. Things that accelerate the illness and might even become more important than amyloid at that later stage of the illness. We see the stress on the brain cells that affects their survivability.' Prof Rowe added: 'There has been a lot of effort put into the amyloid story but in parallel, there's been a huge commitment to the alternative routes to a cure… We will be looking to tailor the right combination of drugs to the right person at the right stage of the illness.' Emma Mead, of the Oxford Drug Discovery Institute, said: "Alzheimer's is a complicated illness. It has many parts to it, but each of those parts in themselves are treatable." The global review shows an 11% increase on dementia drugs going through trials when compared to the previous year. A third of the drugs going through trials are existing medicines currently used to treat different conditions such as diabetes, high blood pressure and viral diseases. Repurposing existing drugs - which have already been shown to be safe after decades of use in the general population - fast tracks the typical 10 to 15 years of trials and testing it takes to develop completely new drugs. Four late-stage trials are even looking at preventing dementia before it has developed. Prof Rowe said there was an 'aspiration to prevent, not just treat', starting by testing drugs on people who have 'a genetic mutation that more or less guarantees the development of Alzheimer's disease'. Prof Rowe said experimental drugs were being trialled on these people in 'early to mid-life' to see if they stop dementia developing or can delay it. He added: "One of the most exciting things of this report is the number of large-scale late-stage trials on prevention. One way this can work is you take a treatment that you show to be working in people with symptoms with the illness, and then you simply bring it forward by some years." Dr Richard Oakley, associate director of research at Alzheimer's Society, said: "This paper shows that 2025 is shaping up to be a landmark year for Alzheimer's disease drug development. With more trials under way than ever before and more drugs entering the pipeline, there is hope on the horizon for the nearly one million people living with dementia in the UK." If you have concerns about dementia, several resources are available in the UK. You can contact the Alzheimer's Society Dementia Support Line at 0333 150 3456 for information and advice. You can also call the Dementia UK Admiral Nurse Dementia Helpline at 0800 888 6678 for specialist support from dementia nurses. Age UK provides advice and support through their Advice Line at 0800 055 6112. Anyone can take part in dementia research whether they are generally healthy, have concerns about memory and thinking or have received a dementia diagnosis. Click HERE to find out more about taking part in dementia trials.
The Sun
15 hours ago
- The Sun
The £3.50 M&S buy homeowners are using to make their whole house smell like a ‘boujee candle' without a single flame
A HOMEOWNER has revealed how she gets her whole house to smell like she's had a "boujee candle" burning all day - without lighting a single flame. Hannah explained she's a big fan of the cleaning products in Marks & Spencer, with the green tea and bergamot £3.50 concentrated disinfectant among her favourites. 3 3 And as well as using the liquid in its intentional way, she's also figured out a clever hack to make her home smell like the scent. "Fill a sink with some M&S disinfectant and your house will smell like you've burnt a boujee candle all day!" she wrote over a video on her TikTok page. "I'm sorry but this smell..." she captioned the video. And people were quick to comment on the clip, with one writing: "Need to try this, love their cleaning products!" "The almond toilet gel as well," Hannah replied. "Ooh this would be great in my hand steamer too," another added. "Just need to check it's pet friendly!" "I fill a dishmatic brush and do my radiators and skirtings every few days too," a third revealed. "We do this too!" someone else added. "Yessss I do this with Zoflora when it's on sale," another admitted. Shoppers are racing to buy 'nostalgic' homeware from M&S - it's like being 'transported back in time' & looks 'designer' And the positive reviews of the disinfectant kept on coming in the reviews section on the Ocado website - where you can nab the product online. "I just love the floral fragrance- doesn't smell like a disinfectant at all and makes the house smell clean, fresh and lovely," one wrote. "This product smells amazing ,subtle but also fragrant enough that a little goes a long way," another added. "I always add a couple of capfuls to my weekly wash and makes the laundry smell really fresh. "I also add some to my reed diffusers when they are running out of fragrance and they make the whole house smell clean and fresh." "Lovely long lasting smell, smells divine," a third commented. "Good value when compared with leading brands," someone else wrote. "Very long-lasting fresh and floral fragrance." The disinfectant also comes as a spray, in the same scent, with one person writing in their review on Ocado: "Always keep this spray handy for holidays and trips and completely blitz wherever were staying. "Toilet flush, tv remote, door handles, light switches etc. "It smells really nice and seems to last a long time too!"
Daily Mail
a day ago
- Daily Mail
American living in the UK slams the taste of British chicken - before realising huge error
An American woman living in the UK has had a rude awakening after accidentally consuming raw chicken. Gizelle Cade, who is from California but now lives in the UK, shared a video to TikTok in which she branded a breaded chicken product from Marks & Spencer 'so gross'. In the clip, she held a piece of half-eaten chicken up to the camera to show the pink flesh and blood near the bone inside. Criticising the chicken, Gizelle said: 'For the record, if you are ever eating chicken that has this kind of pink in it, it is bad. 'It's really, really bad. Look at that. So gross.' She wrote in the caption: 'Tried M&S chicken. It was pink. Emetophobia kicked in. Instant panic.' Emetophobia is the fear of vomit. Those who suffer from it often avoid foods that could make them sick and throw up, including undercooked meats that could lead to food poisoning. However, Gizelle was quickly corrected by British viewers, who pointed out that unless she had bought the chicken from the picnic foods section of M&S, the meat required cooking before it could be eaten. However, it transpired that the American had no idea the breaded chicken product had to be cooked at a high temperature for a set amount of time before it could be eaten In one of her replies to comments, it was apparent she was under the impression that the chicken only needed to be heated, not cooked. She said: 'It was cooked, it's the Southern Chicken that comes cooked, all you gotta do is heat it.' But others reiterated that the product would have had to be cooked in the oven or air fryer for a certain amount of time, and the instructions were stated on the package. 'It's part cooked,' one person clarified, while another added: 'It literally says that you need to cook it.' 'It's not a ready cooked product,' a third explained. 'She bought it from the RAW MEAT section, didn't bother to read the packaging and just dug in. 'The top of the packaging literally says 'NEEDS COOKING' and there's detailed cooking instructions on the back.' In a follow-up video, Gizelle realised her error thanks to comments from viewers. 'You literally just changed my life in like two seconds with one comment,' she said in reply to a message clarifying that the chicken needed to be fully cooked in the oven. M&S's breaded chicken range can be found in the raw meat section and each package has detailed instructions on how to cook it in the air fryer or oven However, Gizelle was still unhappy with the popular M&S product, explaining that the chicken already looks cooked thanks to its breaded exterior. 'This is the chicken that I was telling you guys was making me sick - why does it say 'needs cooking'?' she asked. 'Why does the chicken look like this, why do I have to cook it? Now I have more problems with the UK.' She added in her caption: 'Proof one should never assume. Why did I go to get the chicken and it looks like my husband had some too! Lol! Hopefully he read the box.' British TikTok users were largely unimpressed by Gizelle's complaint, but a few attempted to explain why the chicken is sold already breaded and partially cooked. 'They sell it pre-breaded so you can cook and eat it fresh,' one person said. 'We all know pre-cooked chicken is dry as hell. 'Unless it says 'ready to eat' on packaging, assume you need to cook it.' Another added: 'Just because it's breaded doesn't mean it's cooked, friend! Also it's a requirement to shelve cooked and uncooked meats on different sections in a shop to avoid confusion, so you would've had to have bought it from the aisle/shelving units containing other raw meats.' British viewers were quick to inform Gizelle that she was meant to cook the chicken before eating it, and it was revealed she thought it only had to be heated Some people explained why the chicken looked cooked but needed to be put in the oven at home, while others bluntly told the American creator of her error Others were less sympathetic to her grievance, to put it mildly. 'Why does it say 'needs cooking'... That'll be because it needs cooking. Hope this helped,' a commenter wrote. 'This is entirely on you, darling,' another said, while a third added that this was 'the definition of user error'. 'Why don't you read the label? Sis please,' one person commented, to which Gizelle replied: 'Girl, I assumed.' M&S's breaded chicken range, which is stocked in the raw meat section in-store, includes cooking instructions to either air fry or oven cook the product at high temperatures to ensure it's cooked all the way through before eating. The range also includes flavours such as Hot Honey Chicken Tenders, Korean Chicken Bites, Buttermilk Chicken Tenders, Mighty Cajun Chicken Tenders, and Tempura Chicken Tenders.
